Design &amp; synthesis of novel oxazolone &amp; triazinone derivatives and their biological evaluation as COX-2 inhibitors

Mohamed, Lamia W.; El-Badry, Ossama M.; El‐Ansary, Afaf; Ismael, Ahmed S.

doi:10.1016/j.bioorg.2017.04.012

Cited by 22 publications

(15 citation statements)

References 18 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Altogether,t his study established the fact that oxazolone derivatives can be investigated for the development of effective anti-inflammatory agents. [44] In 2017, Kus et al synthesised and evaluated the antioxidant potentialo fo xazole-5(4H)-one derivatives. Their work was focused on countering the oxidative cellular damaget hat leads to development of cancers, cardiovascular diseases and ageing.…”

Section: Pharmacological Profiles Of Oxazolone Derivativesmentioning

confidence: 99%

The Current Status of O‐Heterocycles: A Synthetic and Medicinal Overview

Singh

Silakari

2018

ChemMedChem

View full text Add to dashboard Cite

O-Heterocycles have been explored in the field of medicinal chemistry for a long time, but their significance has not been duly recognised and they are often shunned in favour of N-heterocycles. The design of bioactive molecules for nearly every pathophysiological condition is primarily focused on novel N-heterocycles. The main reasons for such bias include the ease of synthesis and possible mimicking of physiological molecules by N-heterocycles. But considering only this criterion rarely provides breakthrough molecules for a given disease condition, and instead the risks of toxicity or side effects are increased with such molecules. On the other hand, owing to improved synthetic feasibility, O-heterocycles have established themselves as equally potent lead molecules for a wide range of pathophysiological conditions. In the last decade there have been hundreds of reports validating the fact that equally potent molecules can be designed and developed by using O-heterocycles, and these are also expected to have comparably low toxicity. Even so, researchers tend to remain biased toward the use of N-heterocycles over O-heterocycles. Thus, this review provides a critical analysis of the synthesis and medicinal attributes of O-heterocycles, such as pyrones, oxazolones, furanones, oxetanes, oxazolidinones, and dioxolonones, and others, reported in the last five years, underlining the need for and the advantages guiding researchers toward them.

show abstract

Section: Pharmacological Profiles Of Oxazolone Derivativesmentioning

confidence: 99%

The Current Status of O‐Heterocycles: A Synthetic and Medicinal Overview

Singh

Silakari

2018

ChemMedChem

View full text Add to dashboard Cite

show abstract

“…Of these, unsaturated oxazolones present a particular importance both for the organic synthesis, as intermediates in the obtaining of other classes of compounds, as well as for their biological properties [1,2]. A large number of derivatives from this class are reported in the literature as having biological activity, such as antitumoral [3,4], antibacterial [5][6][7][8][9][10], antifungal [5,8,9], anti-inflammatory [11], antioxidant [5,12], tyrosinase inhibitors [13,14].…”

mentioning

confidence: 99%

“…Among the heterocyclic compounds obtained from unsaturated oxazolones are the triazinones cited in the literature for different biological properties, including antitumoral [15,16], antibacterial [17][18][19], antifungal [17], antioxidant [18], anti-inflammatory [11], anticonvulsant [20].…”

mentioning

confidence: 99%

Synthesis, characterization and Cytotoxicity Evaluation of New Compounds from Oxazol-5(4H)-Ones and 1,2,4-Triazin-6(5H)-Ones Classes

Rosca¹,

Apostol²,

Drăghici³

et al. 2019

Rev. Chim.

View full text Add to dashboard Cite

This paper presents the synthesis of new heterocyclic compounds from oxazoles and triazinones classes. Some 2-(4-(4-X-phenylsulfonyl)benzamido)acetic acids were condensed with 4-iodobenzaldehyde in presence of acetic anhydride and sodium acetate, when the new corresponding unsaturated oxazol-5(4H)-one were obtained. Through the reaction of these oxazol-5(4H)-ones with phenylhydrazine, in presence of the acetic acid and sodium acetate, the new heterocyclic compounds from 1,2,4-triazin-6(5H)-ones class were obtained. The structures of synthesized compounds have been confirmed by spectral methods (FT-IR, 1H-NMR, 13C-NMR and MS) and elemental analysis. The cytotoxicity of the compounds was evaluated using the Daphnia magna and Artemia salina bioassays.

show abstract

“…There are many reports that mention various oxazoles and oxazolones derivatives for their biological actions, such as antimicrobial [1][2][3], antitumoral [3][4][5], analgesic and anti-inflammatory [3,[6][7][8][9][10], including the antagonistic action upon transient receptor potential cation channel subfamily V member 1 (TRPV1) channel [11]. Moreover, there are drugs with anti-inflammatory activity containing the oxazole nucleus, being currently used in therapy.…”

Section:  Introductionmentioning

confidence: 99%

“…Moreover, there are drugs with anti-inflammatory activity containing the oxazole nucleus, being currently used in therapy. For example, oxaprozin is a non-steroidal anti-inflammatory drug with an 1,3-oxazolic nucleus that blocks prostaglandin synthesis by non-selective inhibition of both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), that is used in the treatment of many musculoskeletal inflammatory diseases [6,12,13].…”

Section:  Introductionmentioning

confidence: 99%

New 2-(4-(4-bromophenylsulfonyl)phenyl)-4-arylidene-oxazol-5(4H)-ones: analgesic activity and histopathological assessment

Bărbuceanu

Roşca

Apostol

et al. 2020

Rom J Morphol Embryol

View full text Add to dashboard Cite

This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited. ORIGINAL PAPER New 2-(4-(4-bromophenylsulfonyl)phenyl)-4-arylideneoxazol-5(4H)-ones: analgesic activity and histopathological assessment FLORICA BĂRBUCEANU 1,2) , ELENA-VALENTINA ROŞCA 3) , THEODORA-VENERA APOSTOL 3) , OANA-CRISTINA ŞEREMET 4) , CONSTANTIN DRĂGHICI 5) , DRAGOŞ PAUL MIHAI 4) , SIMONA NEGREŞ 4) , GEORGE MIHAI NIŢULESCU 6) , ŞTEFANIA-FELICIA BĂRBUCEANU 3)

show abstract

Design & synthesis of novel oxazolone & triazinone derivatives and their biological evaluation as COX-2 inhibitors

Cited by 22 publications

References 18 publications

The Current Status of O‐Heterocycles: A Synthetic and Medicinal Overview

The Current Status of O‐Heterocycles: A Synthetic and Medicinal Overview

Synthesis, characterization and Cytotoxicity Evaluation of New Compounds from Oxazol-5(4H)-Ones and 1,2,4-Triazin-6(5H)-Ones Classes

New 2-(4-(4-bromophenylsulfonyl)phenyl)-4-arylidene-oxazol-5(4H)-ones: analgesic activity and histopathological assessment

Contact Info

Product

Resources

About